2024年2月15日，国际巨头帝斯曼-芬美意(以下简称公司)在官网上发布公告，表示将启动剥离旗下动物营养与保健业务的流程。

　　公司认为动物营养与保健板块的驱动力与公司其他板块不同，尤其是在维生素市场面临前所未有挑战的当下，这一点变得更加明显。公司认为，动物营养与保健业务的全部潜力可以通过不同的所有权结构来更好的兑现，所有潜在的分离方案都将被考虑在内。公司预计将在2025年实现业务分离。

　　帝斯曼-芬美意首席执行官Dimitri de Vreeze对此评论道：“我们在帝斯曼-芬美意的目标是为生活带来进步，因此我们推动优质、高增长和有弹性的细分市场的创新。动物营养与保健板块是一项出色的业务，多年来我们一直致力于成为行业的真正领导者。这是一个艰难的时刻，但我们坚信，分离对企业及其员工都会更好，并最终让我们所有的利益相关者受益。”

　　分离将使帝斯曼-芬美意能够加强其在营养、健康和美容领域的世界领先地位。专注香水与美容(P&B);口感、质地和健康(TTH);以及健康、营养和护理(HNC)，该公司可以进一步发展其互补的世界级科学研究、技术和卓越制造。对这些业务的全面关注有望增强其商业潜力和协同效应，支持有吸引力和持续的增长前景以及强劲的利润率。

　　作为这一过程的一部分，预计将被剥离的动物营养与保健业务范围正在进行审查。考虑到Bovaer在整个乳制品行业(TTH的一个重要部门)减少排放方面的关键作用，以及Veramaris在膳食补充剂方面的巨大潜力，预计这两项业务仍将是集团的一部分。

　　Ivo Lansbergen将继续领导动物营养与保健业务。他于1997年加入动物营养与保健板块，自2019年起领导动物营养与保健板块。

　　Ivo Lansbergen，动物营养与保健总裁，评论道：“我们在动物营养与保健内部有一个令人惊叹的团队，他们建立了一个具有规模、独特的投资组合和无与伦比的创新能力的全球领导者，以帮助我们的客户解决一些最具挑战性的粮食安全问题，并制定了一项专注于使畜牧业可持续发展的战略。对于我们的世界级团队来说，推行我们的动物营养与保健战略是一个令人兴奋的前景。”

　　帝斯曼芬美意的动物营养与保健板块是一家世界领先的企业，拥有最完整的配料组合，能够通过更可持续的畜牧业支持不断增长的人口。动物营养与保健板块总部位于Kaiseraugst，去年实现了超过30亿欧元的收入，约有6000名员工。它帮助客户高效、可持续地提供健康的动物蛋白，同时利用数据的力量使动物养殖实践更加可持续、高效和透明。该公司在世界各地拥有独特的预混料网络，有助于通过本地解决方案提供全球产品，并受益于精准服务能力。

　　全球维生素市场经历了长期低迷，这主要是由于动物市场维生素价格面临前所未有的周期性压力。性能解决方案业务的强劲成果在一定程度上缓解了这一问题，该业务为农民提供了实现饲料效率产量管理的重要工具。通过分离动物营养与保健板块，帝斯曼芬美意对未来维生素收益波动的敞口将减少。

　　作为2023年6月宣布的维生素转型计划的一部分，该公司继续在其成本削减计划方面取得重大进展，包括关闭工厂、简化通往市场的路线和优化服务水平。公司仍有信心在2024年实现1亿欧元的调整后息税折旧摊销前利润贡献，并在2025年实现2亿欧元的全部收益。

　　在此过程中，帝斯曼芬美意仍然致力于动物营养与保健业务及其市场领先的团队，并在业务过渡到新的所有权结构以充分发挥其潜力时为客户提供卓越的服务。

　　公告原文：

　　dsm-firmenich to separate out Animal Nutrition & Health business from the Group

　　Kaiseraugst (Switzerland), Heerlen (Netherlands), February 15, 2024

　　dsm-firmenich (the “Company” or the “Group”), innovators in nutrition, health, and beauty, announces today the initiation of a process to carve-out and separate out the Animal Nutrition & Health (“ANH”) business from the Group. ANH is driven by different dynamics to the rest of the Group, which has become even more apparent with the unprecedented challenges in the vitamins market. The Company believes that the full potential of the ANH business could be best realized through a different ownership structure for which all potential separation options will be considered. The Company would expect to be in a position to separate the business in the course of 2025.

　　Dimitri de Vreeze, CEO of dsm-firmenich, commented: “Our purpose at dsm-firmenich is to bring Progress to Life, as we boost innovation in premium, high-growth and resilient segments. ANH is a fantastic business that over the years we have built to be a true leader in the industry. This is a difficult moment, but we strongly believe that a separation would be better for both businesses and their employees, and ultimately generate better value for all our stakeholders.”

　　A separation would enable dsm-firmenich to strengthen its position as a world-leader in nutrition, health, and beauty. By fully focusing on Perfumery & Beauty (P&B); Taste, Texture & Health (TTH); and Health, Nutrition & Care (HNC), the Company can further develop its complementary world-class scientific research, technologies and manufacturing excellence. Full focus on these businesses is expected to enhance their commercial potential and synergies, supporting an attractive and consistent growth outlook alongside robust margins.

　　The perimeter of the ANH business expected to be separated out is being reviewed as part of this process. Given Bovaer’s critical role in reducing emissions across the dairy industry, an important segment for TTH, and Veramaris’ significant potential in dietary supplements, it is expected that both businesses would remain part of the Group.

　　Ivo Lansbergen will continue to lead the ANH business. He joined in 1997 and led ANH since 2019.

　　Ivo Lansbergen, President, Animal Nutrition & Health, commented: “We have an amazing team within ANH that has built a global leader with scale, a unique portfolio and unrivalled innovation capabilities to help our customers tackle some of the most challenging food security issues and with a strategy that is strongly focused on Making Animal Farming Sustainable. It is an exciting prospect for our world class team to pursue our ANH strategy.”

　　ANH is a world leading business with the most complete ingredients portfolio ideally positioned to support a growing population through more sustainable animal farming. Headquartered in Kaiseraugst, last year ANH delivered more than €3 billion in revenues with approximately 6,000 employees. It helps its customers to deliver healthy animal proteins efficiently and sustainably whilst harnessing the power of data to make animal farming practices more sustainable, productive, and transparent. The business has a unique premix network across the world that helps deliver global products with local solutions and benefits from precision services capability.

　　The global vitamins market has experienced a prolonged downturn which has been driven primarily by unprecedented cyclical pressure on vitamin prices in the animal markets. This has been partly mitigated by strong outcomes from the performance solutions business which provides important tools for farmers to deliver feed efficiency yield management. By separating ANH, dsm-firmenich’s exposure to future vitamin earnings volatility would be reduced.

　　As part of the vitamin transformation program announced in June 2023, the Company continues to make significant progress on its cost reduction plan including plant closures, route-to-market simplification, and optimized service levels. The Company remains confident in realizing a contribution of €100 million in adjusted EBITDA in 2024 and the full benefit of €200 million in 2025.

　　During the process, dsm-firmenich remains committed to the ANH business, its market-leading team and to providing excellent service to customers as the business transitions to a new ownership structure to deliver its full potential.